Abstract: Activation of T cells is dependent on organized and timely opening and closing of chromatin. Herein, we identify AP-1 as the transcription factor that directs most of this remodeling. Chromatin accessibility profiling showed quick opening of closed chromatin in naïve T cells within 5 hours of activation. These newly open regions were strongly enriched for the AP-1 motif, and indeed, ChIP-seq demonstrated AP-1 binding at more than 70% of them. Broad inhibition of AP-1 activity prevented chromatin opening at AP-1 sites and reduced expression of nearby genes. Similarly, induction of anergy in the absence of costimulation during activation, was associated with reduced induction of AP-1 and a failure of proper chromatin remodeling. The translational relevance of these findings was highlighted by the substantial overlap of AP-1-dependent elements with risk loci for multiple immune diseases, including multiple sclerosis, inflammatory bowel disease and allergic disease. Our findings define AP-1 as the key link between T cell activation and chromatin remodeling.
Introduction
Upon encountering an antigen, naïve T helper cells are activated and differentiate over several days into various effector lineages that contribute to immune responses (O'Shea and Paul, 2010; Russ et al., 2013) . These differentiated effector cells secrete different sets of cytokines and have specific functions in orchestrating immune responses against pathogens. In the contraction phase of the response, most effector cells die, but a few survive and become long-lived memory cells (Ben Youngblood et al., 2017) . We and others have demonstrated that epigenetic states induced during T cell activation, differentiation, and memory formation are associated with T-cell lineage stability and plasticity, cytokine production in effector cells, and rapid recall response in the memory cells (Vahedi et al., 2012; Barski et al., 2009; Komori et al., 2015; Smith et al., 2009; Hawkins et al., 2013; Mukasa et al., 2010; Mazzoni et al., 2015; Sekimata et al., 2009; Wei et al., 2009; Ohkura et al., 2012 ). An outstanding question in the field is how the epigenetic changes are induced and targeted to specific loci during primary activation of T cells.
The differentiation of T cells is a multi-step process starting with T cell activation. The activation is accomplished through simultaneous stimulation of the T cell receptor (TCR) and co-stimulatory receptors such as CD28. Downstream NFATs, AP-1 (a heterodimer of FOS and JUN proteins), and NFB are activated via Ca 2+ -calcineurin, MAP kinase and PI3K/PKC pathways (Fathman and Lineberry, 2007; Crabtree and Olson, 2002; Jain et al., 1994; Rochman et al., 2015) . Concurrently with activation signals, differentiation signals provided by the cytokine milieu lead to activation of JAK-STAT pathways, induction of lineagespecific transcription factors (TFs), and eventually lineage-specific cytokine gene expression . The Il2 locus has previously been used as a model to study activationinduced transcriptional regulation. The Il2 promoter has several AP-1 and NFAT binding sites that are conserved between human and mouse (Rooney et al., 1995; Macian et al., 2001 ). The binding sites are adjacent, and AP-1 and NFAT form a heteromer (Jain et al., 1994; Chen et al., 1998) and synergize to induce Il2 expression (Walters et al., 2013; Nguyen et al., 2010) . Mutation of these binding sites prevents Il2 expression (Walters et al., 2013) . NFB and several other TFs also participate in Il2 regulation during T cell activation via their binding sites near the promoter (Thaker et al., 2015; Skerka et al., 1995) . However, the mechanisms of transcriptional regulation during T cell activation are not common for all genes. For example, IL2 expression is dependent on new protein synthesis, but IL10, IFNG, and TNF are not (Sareneva et al., 1998) .
Herein, we profiled chromatin accessibility during the early stages of T cell activation in human primary naïve CD4 T cells. We were struck by the massive number of regions undergoing remodeling within 5 h of activation and by the considerable enrichment of AP-1 motifs. Chromatin immunoprecipitation (ChIP-seq) demonstrated AP-1 binding at the majority of these regions, often together with its partner NFAT1. AP-1 was also strongly present at super enhancer (SE) elements formed during activation. Whereas prior studies have focused on genetic disruption of individual AP-1 members, herein we broadly blocked the AP-1 family in human naïve T cells by electroporating a dominant-negative protein (A-FOS); this resulted in loss of chromatin remodeling and T cell activation. Conversely, AP-1-associated chromatin changes were absent during induction of T cell anergy. The translational significance of these findings to clinical medicine was supported by the overlap of activationspecific enhancers and AP-1 binding sites with single-nucleotide polymorphisms (SNPs) associated with increased risk for a variety of diseases, most substantially found for multiple sclerosis.
hallmarks of enhancers and strong enhancers, respectively (Ernst et al., 2011) . In conjunction with the EOR association with transcriptional upregulation, these findings suggest that the EOR are likely to serve as transcriptional enhancers.
Transcription factors AP-1 and NFAT1 bind effector open chromatin regions
To identify TFs that may play a role in chromatin remodeling during activation, we applied the HOMER software (Heinz et al., 2010) to identify TF binding sites over-represented within the differentially accessible regions (Fig. 3 A and Fig. 2 A and B) . Analysis showed that DNA motifs of AP-1 or the AP-1/NFAT composite element were enriched in EOR but not in NOR and COR. Interestingly, the NFAT motif alone was not enriched as strongly. BORIS and CTCF motifs were prominent at the EOR sites not bound by AP-1 (Fig. S2 C) , suggesting that nuclear organization may be also affected by activation-induced chromatin opening. In contrast to EORs, NORs were enriched in motifs for EGR and KLF, which have been reported to be negative regulators of T cell activation (Safford et al., 2005) and to maintain the naïve state in T cells (Yamada et al., 2009) . For COR, motifs of ETS, which is important in T cell development and activation (Panagoulias et al., 2016; Muthusamy et al., 1995) , were prominent. Indeed, enrichment of JunB motifs and binding at the sites of chromatin remodeling was previously reported in mouse T cells (Bevington et al., 2016) . To test whether AP-1 and NFAT TFs actually bind EORs in human T cells, we performed ChIP-seq for cFOS and JUNB (components of AP-1), NFAT1, NFAT2, NFB, and cMyc, which are known to be important for T cell activation and proliferation (Liu et al., 2016; Trushin et al., 1999; Wong et al., 1999; Chou et al., 2014; Wang et al., 2011) . cFOS, JUNB, and NFAT1 were present in EORs more than in NORs and CORs, whereas NFB and cMyc were not enriched in EORs (Fig. 3 B) . For example, the TNFRSF18 gene locus had two EOR regions (Fig. 3 C) . One of them was bound by AP-1 and NFAT1, but the other was only bound by AP-1. Previously, it was reported that AP-1 and NFAT formed a heteromer on the IL2 promoter (Chen et al., 1998) , leading us to examine combinatorial effects of the TFs on the opening of chromatin genome-wide (Fig. 3 D) . Remarkably, more than 70% of EOR were bound by AP-1 (cFOS/JUNB) alone or AP-1 and NFAT1 together. Further, almost all NFAT1-bound EOR were also bound by AP-1 (cFOS or JUNB). Interestingly, the triple combination of cFOS, JUNB, and NFAT1 resulted in the highest accessibility, followed by the cFOS/JUNB dimer, whereas NFAT1 sites not bound by AP-1 showed minimal opening (Fig. 3 E) in agreement with the NFAT-only motif not being enriched in EORs. Moreover, the H3K27Ac level was also the highest in regions with the triple combination (Fig. S3 A) . Furthermore, the level of chromatin openness was correlated with the strength of cFOS, JUNB, and NFAT1 binding, (Fig. S3 B) . These data suggest either a role for AP-1 in chromatin remodeling during T cell activation or passive binding of AP-1 complexes to enhancers opened by other TFs.
Formation of super enhancers involves chromatin opening
Combinations of several nearby enhancer elements with unusually high total level of H3K27 acetylation and/or binding of Mediator or BRD4 proteins are known as super enhancers (SEs) and are believed to induce expression of cell type-specific genes (Whyte et al., 2013 ; Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers, 2013) . Therefore, we examined whether EORs were involved in the assembly of SEs. We identified 640 and 384 SEs in naïve and activated T cells, respectively, and 203 of them were shared between the cell states ( Fig.  S4 A and B) . As expected, the presence of SEs resulted in high expression of nearby genes (Fig.  S4 C) . SE formation during T cell activation was associated with chromatin remodeling. For example, the IL2RA SE formation was accompanied by open chromatin formation after activation (Fig. 4 A and B) . In addition to the EOR frequency being higher in activated SE (28.3 EOR/ 1 Mb), the frequency of EORs also was higher in shared SE (24.4 frequency EOR/ 1 Mb) (Fig. 4 C) . SEs in naïve cells seem to rely on NOR and COR in contrast to SE in activated cells (Fig. 4 C and Fig. S4 D and E) . Furthermore, AP-1 and NFAT1 were bound to activated and shared SEs at high frequency in contrast to naïve SEs (Fig. 4 D) . Collectively, these results suggest that AP-1 and NFAT1 likely play a role in the formation of SEs during T cell activation.
AP-1 activity is required for open chromatin formation during T cell activation
In order to examine the role of AP-1 in the formation of open chromatin, we sought to inhibit AP-1 activity during T cell activation. Unfortunately, due to co-expression of multiple JUN and FOS family members in T cells and their common upregulation during activation (Fig. 5 A) (Jain et al., 1994) , knock-out or knock-down strategies are unlikely to be successful. For this reason, we instead used the AP-1 dominant-negative protein A-FOS (Biddie et al., 2011) . A-FOS can sequester JUN isoforms and prevent FOS-JUN complex formation and DNA binding. Bacterially expressed A-FOS or GFP control proteins were purified and electroporated into naïve T cells before activation. Electroporation efficiency was close to 100%, and GFP electroporation did not affect T cell activation (data not shown). We observed that in the A-FOS-electroporated cells, chromatin opening was decreased at EORs but not at NORs and CORs (Fig. 5 B) . This blocking effect was more significant in EORs strongly bound by AP-1 (Fig.  5 C) , and the effect appeared to be site-specific: an EOR bound by AP-1 was affected in the IRF8 locus, whereas an EOR not bound by AP-1 was not affected (Fig. 5 D) . The specific effect of A-FOS protein transduction provides reassurance that the electroporation procedure was functional and well received by the T cells. Furthermore, inhibiting AP-1 resulted in downregulation of activation-inducible genes such as TBX21, IFNG, and CSF2 (Fig. 5 E) . These results indicate that AP-1 binding is required for opening chromatin during T cell activation at many genomic loci.
Co-stimulation is required for open chromatin formation
In order to better understand the role of AP-1-induced chromatin remodeling in the greater context of the immune response, we next performed T cell activation in the absence of CD28 co-stimulation (Fig. 6 A) . Previous studies have shown that the lack of co-stimulation reduces activation of AP-1 and eventually leads to the induction of anergy (Macian et al., 2002; Kriegel et al., 2009; Rochman et al., 2015) . Indeed, cells not receiving CD28 co-stimulation (Anergy) showed dramatic reduction of nuclear translocation of AP-1 and to a smaller degree NFB p50, whereas nuclear levels of NFATs and NFB p65 were reduced only slightly (Fig. S6 A) . Genome-wide, the reduction of AP-1 activity was accompanied by decreased chromatin opening at EORs (Fig. 6 B and C). For example, in the absence of CD28 signaling, the AP-1-bound EOR in the vicinity of the JAK2 gene was not remodeled and did not become acetylated on H3K27 ( Fig. 6 D) ; consequently, JAK2 demonstrated reduced gene expression (Fig. 6 E) . The promoter-associated COR, also bound by AP-1, remained but with decreased H3K27Ac levels. Interestingly, NFAT binding was still detectable at the majority of sites including those that lost the ATAC signal in the absence of co-stimulation, suggesting that NFAT is not sufficient for opening chromatin (Fig. 6 D and Fig. 5S B) . Failure of EOR formation in co-stimulationdeficient cells was especially prominent in regions that have higher openness among EORs in effector-activated cells at 24 h (Fig. 6 C) . We tested whether failure of chromatin remodeling due to the lack of CD28/AP-1 affected the histone modifications and transcriptome in cells that did not receive co-stimulation. Indeed, failure of open chromatin formation led to reduced H3K27Ac level and gene expression at nearby genes (5 h, Spearman R = 0.13, p = 4.4e-15; 24 h, Spearman R = 0.32, p = 3.6e-87) (Fig. S5 C and D) . These results suggest that induction of anergy by activation in the absence of co-stimulation is associated with the failure of AP-1-dependent chromatin remodeling.
Discussion
T cell activation is associated with dramatic chromatin de-condensation that is essential for T cell differentiation and function (Rawlings et al., 2010; Lee et al., 2015) . Genome-wide regulatory elements are bound by TFs that recruit chromatin-remodeling complexes and chromatin-modifying enzymes, leading to expression of activation-related genes. We mapped putative regulatory elements in human naïve and activated CD4 T cells by ATAC-seq and identified the regions that undergo remodeling at early time points during T cell activation. Many of them stay open in the resting memory cells. These regions also gained "positive" histone modification, such as H3K4me3 and H3K27ac, whereas the nearby genes tended to demonstrate increased expression. Interestingly, these regulatory elements showed significant overlap with SNPs associated with a number of immune diseases, underscoring their importance for the regulation of the immune system. Next, we identified the TF binding motifs that are present at the sites of remodeling and thus may control chromatin remodeling at these elements. To confirm the results of the computational analysis, we monitored actual binding of NFAT1 and AP-1, as well as NFB and cMYC, during activation by ChIP-seq. Comparing TF binding and chromatin opening data suggested that AP-1 is the factor responsible for opening chromatin at regulatory elements during T cell activation. Indeed, delivery of the AP-1 dominant-negative protein A-FOS into naïve T cells resulted in the T cells' failure to remodel chromatin. Finally, we found that lack of the AP-1 activation during induction of anergy resulted in a failure of T cells chromatin remodeling.
It has long been known that activation of T cells requires two signals. Work from the Rao laboratory and others has shown that insufficient induction of AP-1 in the absence of costimulation fails to induce Il2 gene expression and eventually leads to anergy (Macian et al., 2002; Kriegel et al., 2009; Rochman et al., 2015) . However, murine cFOS knock-out T cells demonstrated normal response to activation, suggesting that either cFOS was not necessary (Jain et al., 1994) or that the other FOS family members, such as FOSB, FRA-1, and FRA-2, could substitute for cFOS (Fleischmann et al., 2000; Gruda et al., 1996) . Indeed, all AP-1 family genes are dramatically upregulated upon T cell activation (data not shown). Given that the AP-1 family includes 18 genes, generating a complete deletion was impractical. Furthermore, manipulating expression in resting naïve T cells is difficult because successful viral transduction requires T cell proliferation, and although plasmid electroporation is possible, the process impairs cell activation (data not shown). We overcame this dual problem by (i) employing the A-FOS dominant-negative protein that sequesters JUN family members into unproductive A-FOS/JUN complexes (Biddie et al., 2011) and (ii) electroporating the protein into resting naïve T cells, which (unlike plasmid electroporation) did not affect T cell activation. In the presence of A-FOS, T cells failed to remodel their chromatin at multiple AP-1-bound sites. This experiment explains the role of AP-1 in T cell activation-establishing chromatin remodeling. Without CD28-driven AP-1 induction, naïve CD4 T cells could not establish open chromatin regions to act as enhancer elements for inducing gene expression in T cell activation. Our results further confirmed the hypothesis (Jain et al., 1994 ) that although individual FOS family proteins are redundant, induction of the AP-1 family is critical for T cell activation.
CD4 T cells control functions of other immune cells and are the key regulators of immune response and homeostasis. Impairment of T cell activation may lead to persistent infections and cancer, and over activation of T cells may cause autoimmune or atopic disease. Aside from elucidating the epigenetic mechanism of T cell activation, our data demonstrate a significant overlap between putative regulatory elements employed in T cell activation (EORs) with previously unexplained risk loci for several autoimmune diseases, such as Crohn disease, multiple sclerosis, and inflammatory bowel disease (Fig. 1 F) (Soderquest et al., 2017) . Previously AP-1 sites were found to be enriched near SNPs for autoimmune diseases (Farh et al., 2014) . In order to gain further clues into potential disease mechanisms, we repeated the RELI analysis with TF ChIP-Seq data in order to identify the candidate TFs that may bind risk loci. This analysis revealed that risk loci for multiple immune diseases were enriched for AP-1-and NFAT1 (Fig. 7 A-C) . We next endeavored to check whether the EORs overlapping disease risk loci are differentially open (or modified) in T cell from patients. Although we could not find such data for our top hits (MS and IBD), a recent study (Seumois et al., 2014) reported H3K4me2 profiles for Th2 cells obtained from asthmatics and healthy controls. We found that 2 allergic disease risk loci (CD25 and PHF19) that significantly overlap with EORs (Fig. 7C ) showed significant increase in the level of H3K4me2 in asthma patients compared to healthy controls (FDR<0.1, Fig. 7 D) . These findings indicate the importance of proper chromatin remodeling for immune homeostasis.
How does binding of AP-1 lead to chromatin remodeling? Previous studies have shown that AP-1 proteins can recruit components of BAF chromatin remodeling complex. In particular, SMARCD1 was shown to be AP-1 interacting partner in yeast two-hybrid screen (Ito et al., 2001) . ATF3 was shown to physically interact with SMARCA4 (BRG1-ATPase) (Xu et al., 2011) , while a more recent study showed interaction of FOS with 10 out of 15 BAF members and ability of other FOS family members (FOSD, FOSL1/2) to recruit both SMARCB1 and SMARCD1 (Vierbuchen et al., 2017) .
Other TFs are involved in regulating the epigenome during T cell activation. Recent studies discussed the roles of STATs, GATA3, and T-BET (Vahedi et al., 2012; Durant et al., 2010; Wan et al., 2015; Pham et al., 2013; Kanhere et al., 1AD) . Moreover, although AP-1 is required for chromatin remodeling at the regulatory elements for T cell activation, our study does not completely answer the question of specificity: many cell types express AP-1 and NFATs but do not induce T cell genes such as IL2 (Armstrong, 2004; Turner et al., 1998; Ranger et al., 2000; Jauliac et al., 2002) . Thus, the specificity would need to be established either by a pre-existing epigenetic state or by interaction with additional TFs. For this reason, AP-1 cannot be considered to be a pioneer factor (Zaret and Mango, 2016) just by itself. RUNX family proteins, which are broadly expressed in lymphocytes and regulate expression of IL2 (Djuretic et al., 2006; Ono et al., 2007) and ETS family members (Bevington et al., 2016) may play a role, but involvement of additional TFs is also possible.
Method Isolating, culturing, and activating human CD4 T cells
Blood filters containing cells from de-identified donors were supplied by Hoxworth Blood Center at the University of Cincinnati. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll density gradient centrifugation. Isolated PBMCs were processed with the EasySep™ Human Naïve CD4 + T Cell Isolation Kit (STEMCELL, cat#19555) to negatively isolate human CD4 + /CD45RO -cells (naïve T cells), and the purity was confirmed by flow cytometry (Fig. S1 B) . Isolated naïve T cells were cultured in RPMI media with L-glutamine (HyClone, cat#SH30027.01) supplemented with 10% FBS and 25 M 2-ME before activation. For bead activation, 100 L of anti-mouse pluriBeads (pluriSelect, cat#31-GTaMS-10) were incubated with 24 ng of anti-human CD3 antibody (Bio X Cell, cat#BE0001-2) and 52 ng of either antihuman CD28 antibody (Bio X Cell, cat# BE0248) or mouse IgG (Millipore, cat#12-371) with rotation for 3-4 h at RT. The beads were centrifuged and washed with PBS twice. Antibodybound pluriBeads were directly added to the cultures of human CD4 + T cells, and the cultures were shaken for 4 hr and swirled every 10 min until cells were bound to the beads.
Flow cytometry assay
Cells were stained with PE-Cy™7 Mouse Anti-Human CD45RO, FITC Mouse Anti-Human CD45RA, and FITC anti-human CD69 antibodies. Flow cytometry was performed on the BD FACS Canto II using the BD FACSDIVA.
Isolating nuclear proteins and western blotting
T cells were collected and lysed with nuclear isolation buffer (10 mM HEPES-KOH [pH 8.0], 10 mM KCl, 1.5 mM MgCl2, 0.34M sucrose, 10% glycerol, 1 mM DTT, and 1X protease inhibitors) for 10 min with shaking every 3 min. The nuclear pellet was collected by centrifugation and was suspended and washed with nuclear isolation buffer twice. The nuclear pellet was directly lysed in SDS sample buffer with 8M urea. SDS-PAGE was carried out in the Bolt® Bis-Tris system (Thermo Fisher Scientific). Transfer was carried out with 120 V for 90 min to a PVDF membrane. Blocking of the membrane was performed with Odyssey Blocking Buffer (LI-COR, cat#927-50000) for 60 min at RT with shaking. The antibody incubation was carried out at 4 °C overnight with an orbital shaker. Antibodies to cFOS (#2250), JUNB (#3753), NFAT1 (#5861), NFAT2 (#8032), NFB p50 (#12540), and PARP1 (#9532) from Cell Signaling; NFB p65 (c15310256) from Diagenode; and GAPDH (NB600-502) from Novus were used as primary antibodies. Membranes were washed with TBS-Tween for 5 min 3 times and were incubated with IRDye secondary antibodies in 1/15,000 dilution in blocking buffer for 60 min at RT with shaking. Membranes were washed with TBS-Tween for 5 min 3 times again and with TBS once. Images were taken with an Odyssey Fluorescent Imaging system (LI-COR).
ATAC sequencing (ATAC-seq)
Fifty thousand naïve or activated T cells were collected and processed in a transposase reaction, and library preparation was as described by Buenrostro et al (Buenrostro et al., 2013) .
Chromatin immunoprecipitation (ChIP) and library preparation by ChIPmentation
Fixing solution (50 mM HEPES-KOH [pH 8.0], 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 8.8% formaldehyde) was added directly to T cell culture at a final formaldehyde concentration of 0.88% for fixation. After the incubation for 4 min on ice, 2M glycine solution was added to a final concentration of 125 mM and incubated at room temperature for 10 min to stop fixation. Cells were transferred to tubes and washed with cold PBS twice. All buffers used in the following procedures were supplemented with 1X protease inhibitor solution (SIGMA, cat#P8340) before use. Fixed cells were resuspended in L1 buffer (50 mM HEPES-KOH [pH 8.0], 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100, 1X protease inhibitors) and incubated on ice for 10 min with shaking every 3 min. Isolated nuclei were incubated with L2 buffer (10 mM Tris-HCl [pH 8.0], 200 mM NaCl, 1 mM EDTA, and 0.5 mM EGTA) with rotation for 10 min at RT. Then, isolated nuclei were carefully washed and resuspended in TE+0.1% SDS solution. Cells were sonicated (peak power: 105.0, Duty Factor: 10.0, Cycle/Burst: 200) for 45 sec in microtubes at 4 °C using S220 Focused ultrasonicators (COVARIS) to obtain the 200-500-bp fragments of chromatin. Chromatin solution was centrifuged, and supernatant chromatin was collected. Triton X-100, glycerol, NaCl, and sodium deoxycholate were added into the chromatin solution to final concentrations of 1%, 5%, 150 mM, and 0.1%, respectively. Protease inhibitors were also added.
ChIPs were performed in an IP-Star® Compact automation system (Diagenode). In brief, about 5-10 g of chromatin solution corresponding to 1-2 million cells and 5-10 L of Protein A or G Dynabeads (Thermo) were used per reaction. Antibodies against cFOS (Santa Cruz Biotechnology, sc-7202), H3K27Ac (Diagenode, , or H3K4me3 (Millipore #17-614) were used. The other antibodies were the same as used in western blotting. The Dynabeads were sequentially washed with wash buffer 1 (RIPA 150 mM NaCl: 10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.1% sodium deoxycholate, and 1% Triton X-100), wash buffer 2 (RIPA 250 mM NaCl), wash buffer 3 (50 mM Tris-HCl [pH 8.0], 2 mM EDTA, and 0.2% N-Lauroylsarcosine sodium salt), and wash buffer 4 (TE+0.2% Triton X-100) for 15 min each. Washed Dynabeads were processed with transposase per ChIPmentation protocol to accomplish tagmentation of ChIPed DNA (Schmidl et al., 2015) . Tagmented DNA was incubated with proteinase K in elution buffer (TE with 250 mM NaCl and 0.3% SDS) for 4 h at 65 °C and purified from beads with the Qiagen MinElute DNA kit. PCR amplification and purification were carried out in the same way as for ATAC-seq.
RNA isolation and RNA sequencing (RNA-seq)
Total RNA was isolated with the Aurum™ Total RNA Mini Kit (BIO-RAD, cat#7326820) including on-column DNaseI digest. PolyA selection and fragmentation of RNA were performed according to the TruSeq TM Stranded polyA RNA Sample Preparation Guide from Illumina. The fragmented RNA was subjected to first-strand cDNA synthesis. For second-strand cDNA synthesis and adapter ligation, the IP-Star® Compact automation system was used. After that, library construction was performed according to the Illumina protocol.
Sequencing, read mapping, peak calling, peak comparison, and calculation enrichment
DNA libraries for ATAC-seq, ChIP-seq, and RNA-seq were sequenced on HiSeq2500 (Illumina) at the DNA Sequencing and Genotyping Core at Cincinnati Children's Hospital Medical Center. Sequencing data were deposited to GEO under GSE116698 accession number. Data analysis was performed in BioWardrobe . Briefly, 75-bp reads were aligned to the human genome (hg19) using Bowtie (Langmead et al., 2009) (for ATAC-seq and ChIP-seq) or STAR (Dobin et al., 2013) (for RNA-seq). STAR was supplied with RefSeq annotation. For peak calling in ATAC-seq and ChIP-seq, MACS2 (Zhang et al., 2008) software was used.
Browser screenshots show the coverage by estimated fragments: reads were extended to estimated (by MACS2) fragment length, normalized to total mapped read number, and displayed as coverage on a mirror of the University of California Santa Cruz (UCSC) genome browser.
Peak comparison: MAnorm analysis was performed in BioWardrobe using peaks identified with MACS2 (Shao et al., 2012) . To define NORs and EORs, differential fold enrichment > 2 and FDR ≤ 0.05 thresholds were used. For identifying "common" open chromatin regions (CORs), merged common regions from MAnorm analysis with FDR > 0.05 were used.
Box plots and tag density:
Uniquely mapped reads in ATAC-seq and ChIP-seq samples were extended to MACS2 estimated fragment length. At each nucleotide position, the number of reads mapping there per million of total uniquely mapped reads was calculated and converted into average density over the peak. The density was used for box plots, heatmaps, density profiles, and scatter plots.
Differential expression analysis:
Differential expression in RNA-seq between samples was identified by DEseq2 software, and the p-value was calculated (Love et al., 2014) .
Motif enrichment analysis
Isolated genomic coordinates of open chromatin regions were used for identifying TF motifs by HOMER software (Heinz et al., 2010) . We ran HOMER with the empirical data sets together with the control data sets, which comprised the same length of DNA sequence from the flanking regions within 20,000 bp from each region.
Gene ontology enrichment analysis and GSEA
Isolated genes nearby open chromatin regions were processed with the ToppFun function in the ToppGene Suite (Chen et al., 2007) website (https://toppgene.cchmc.org/enrichment.jsp) for ontology enrichment analysis. GSEA analysis was performed with manually defined gene sets located next to the open chromatin regions (Mootha et al., 2003; Subramanian et al., 2005) .
Identifying SEs
For identifying SEs, ChIP-seq of H3K27Ac and the same criteria and software as described in Whyte et al. and Lovén et al. were used (Whyte et al., 2013 ; Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers, 2013).
Regulatory element locus intersection (RELI)
Briefly, SNPs that are in linkage disequilibrium with index risk SNPs for various disease from NIH GWAS catalog were identified. RELI software was used to calculate their overlap with ChIP-seq and ATAC-seq peaks with risk loci.
Analysis of H3K4me2 data in asthmatic patient.
H3K4me2 data in Th2 cells from asthmatic donors and healthy controls were collected from GSE53646 (Seumois et al., 2014) , and initially processed in BioWardrobe as described above. H3K4me2 data are shown in WUSTL genome browser within BioWardrobe (Zhou et al., 2011) . The H3K4me2 differential enrichment domains between asthmatics and healthy controls were identified by using rgt-THOR software (Allhoff et al., 2016) .
A-FOS and GFP protein preparation
A-FOS and GFP cDNA fragments were amplified from CMV500 A-FOS (Addgene, # 33353) and pmaxGFP (Lonza) vectors by PCR, and a 6xHis-GST DNA fragment was also amplified from pGEX vector. A-FOS, GFP, and 6xHis-GST were individually mixed with digested plasmid DNA (GE Healthcare Life Sciences) with NcoI restriction enzyme in an infusion cloning reaction (TakaraBio). The constructed plasmid was transformed into the BL21 bacterial strain. A single colony was picked and transferred to 10 mL of TB-SB medium (TB:SB = 1:1) with Kanamycin, cultured overnight at 37 °C, transferred to 500 mL of TB-SB medium, and cultured until the optical density at 600 nm reached 0.8. For protein expression, IPTG was added into the culture to a final concentration of 0.5 mM, and bacteria were cultured for another 6-8 h at 34 °C. The bacteria were spun down, washed with PBS twice, and stored at -80 °C. The bacterial pellet was resuspended in 20 mL lysis buffer (50 mM Na2HPO4 pH 8, 300 mM NaCl, 10% glycerol, 0.1% Triton X100, 20 mM imidazole with addition of protease inhibitors, lysozyme [100 g/mL], DNaseI [0.2 /mL], and beta-mercaptoethanol to 1 mM), sonicated with a probe sonicator, and then frozen, thawed, and sonicated again. The lysate was cleared by centrifugation and loaded on a 5-mL HisTrap HP column in Buffer A (50 mM Na2HPO4 pH 8, 300 mM NaCl, 20 mM imidazole) using AKTA Start (GE Healthcare Life Sciences). The bound proteins were eluted by the gradient of Buffer B (50 mM Na2HPO4 pH 8, 300 mM NaCl, 500 mM imidazole). The fractions containing protein were combined and subjected to dialysis against PBS with 1 mM beta-mercaptoethanol overnight. After dialysis, Triton X100 was added to the protein solution, and the His6-GST tag was cut with His-tagged HRV3C protease (Sigma) at RT for 5 h. In order to remove the tags and the protease, imidazole was added to 20 mM, the solution was again passed through a 5-mL HisTrap HP column, and the flowthrough was collected. The purity was confirmed by gel electrophoresis (data not shown). The Endotoxin Removal Beads (Miltenyi Biotec cat# 130-093-657) were used to remove endotoxins.
Protein Electroporation
A-FOS and GFP proteins were electroporated using Neon Nucleofector (Invtirogen) and the Neon™ Transfection System 100 µL Kit (Invitrogen, cat# MPK10025). Isolated naïve cells (3.5 million cells) were mixed with 25 µg of A-FOS or GFP in T buffer and pulsed. For activation, the cells were stimulated 2 h after electroporation as described above. 
